Pharmaceutical Industry Information Portal

Solopharm has launched a new plant for the production of soft dosage forms

Solopharm, one of the leading pharmaceutical manufacturers in Russia, has launched a new, modern plant for the production of...

Production of Insulins under the GEROPHARM Technology Will Be Launched in Venezuela in 2025

On 7 November 2024, Dmitriy Chernyshenko, Deputy Prime Minister of the Russian Federation, appraised the readiness of the ESPROMED...

ChemRar invests one billion rubles in a new plant for the production of pharmaceutical substances in Khimki

Construction is expected to be fully completed by the end of 2024, with full production start-up scheduled for Q1-Q2 2025.

Recommendations on registering medical devices in EAEU adopted

On December 23, the Eurasian Economic Commission's Board meeting adopted the Methodological Recommendations on the content and structure of...

The EEC Collegium approved amendments to the rules for determining OTC categories of medicines

According to the source, the general criteria for classifying drugs as OTC have been supplemented with special criteria for individual active substances.

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...

Production of Insulins under the GEROPHARM Technology Will Be Launched in Venezuela in 2025

On 7 November 2024, Dmitriy Chernyshenko, Deputy Prime Minister of the Russian Federation, appraised the readiness of the ESPROMED...

Radiopharmaceuticals Production Complex Built by Rosatom Starts Medical Supplies to Bolivian clinics

A unique for Latin America complex for radiopharmaceuticals production buit by Rosatom by order of the Bolivian Nuclear Energy...

Binnopharm Group brings its popular antispasmodic to Azerbaijan

Binnopharm Group, a pharmaceutical company and part of Sistema, continues to expand its footprint in the CIS markets. Neobutin,...

Don’t miss your daily PharmProm news.
SUBSCRIBE free here!

GMP-inspections of veterinary manufacturers in the fourth quarter of 2024

The year 2024 is ending. The review for the fourth quarter of 2024 provides information on the inspection of...

GMP-inspections of veterinary manufacturers in the third quarter of 2024

The review for the third quarter of 2024 provides information on the inspection of manufacturers of veterinary medicines for...

GMP-inspections of veterinary manufacturers in the second quarter of 2024

The review for the second quarter of 2024 provides information on the inspection of manufacturers of veterinary medicines for compliance with the requirements of the Good Manufacturing Practice (GMP).

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...

Sanofi-GSK’s Covid vaccine, effective against omicron, could hit the market this year

Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta...

OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures

OSE Immunotherapeutics SA today announces that the Company is one of the first biotech startup companies selected by Microsoft...

Pharmaceutical Drug Production in Russia (June, January–June 2023)

In January–June 2023, Russian manufacturers produced 342.5 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 2.6% from the same period in 2022.

RNC Pharma: Pharmaceutical Drug Production in Russia (May 2023)

In January–May 2023, Russian manufacturers produced 282 billion rubles’ of pharmaceutical drugs (manufacturer’s prices, VAT included), down 5.8% from the same period in 2022.

RNC Pharma: Top 20 Online Pharmaceutical Retailers in Russia in Q1 2023

In January–March 2023, the online sales or reservations of pharmacy products (pharmaceutical drugs and parapharmaceuticals) in Russia were 80.2 billion rubles (end-user prices, VAT included), up 2.3% from January–March 2022 (against 69.6% in Q1 2022, with its rush demand).